WORXE Worlds Online Inc

MariMed Stages the ‘Boston 280E THC Party’ in Boston Harbor To Protest Unfair Cannabis Industry Tax Laws

MariMed Stages the ‘Boston 280E THC Party’ in Boston Harbor To Protest Unfair Cannabis Industry Tax Laws

Inspired by the Boston Tea Party’s 250th Anniversary, Company Management and Employees Dress in Colonial Outfits, Decry Unfair IRS Code 280E

NORWOOD, Mass., July 13, 2023 (GLOBE NEWSWIRE) -- Channeling the Boston Tea Party’s rebellious spirit while dressed in traditional colonial garb, MariMed executives and team members staged the ‘Boston 280E THC Party’ from a boat in Boston Harbor on July 12. In reenacting 1773’s “No taxation without representation” revolt, yesterday’s event protested Section 280E of the Internal Revenue Service Code. Section 280E burdens cannabis companies with paying significantly higher taxes than most U.S. businesses, often resulting in higher product prices for consumers. MariMed Inc. (“MariMed” or the “Company”) (CSE: MRMD) (OTCQX: MRMD), a leading Massachusetts-based cannabis company, surprised the crowds at Boston Harbor when they boarded the Liberty Star schooner, heaved cargo chests emblazoned with “WEED” overboard1 and chanted anti-280E slogans.

Section 280E is a prime example of the unique obstacles that legal cannabis businesses must navigate that significantly increase the cost of conducting business. When calculating their taxes, Section 280E prevents the deduction of ordinary business expenses associated with “trafficking” a Schedule 1 or 2 controlled substance. , yet cannabis remains classified as a federally illegal Schedule 1 controlled substance by the U.S. federal government, on par with heroin. Due to Section 280E, cannabis businesses pay much more in taxes than they would if it were repealed, according to .

As a Boston-based multi-state cannabis operator, MariMed protested in a way that would make the Company’s Patriot ancestors proud – by paying homage to the most famous tax protest in history during the year of the Boston Tea Party’s 250th anniversary. By shining a light on Section 280E’s negative financial impact on legal cannabis operators, MariMed hopes to effectuate policy change geared towards industry growth and advancement.

MariMed CEO and President Jon Levine said, “MariMed is among the most-sound financial companies in cannabis, with top-selling brands in the markets we serve. Our protest was less about us and more to provide a voice for the entire industry. Section 280E is unfair and hampers companies striving to make cannabis accessible for consumers and medical cannabis patients in all legal states. It should be repealed. Doing so would remove an obstacle to our mission to improve people’s lives every day through cannabis.”

Mr. Levine continued, “We applaud some of the states where we operate, including Massachusetts, Illinois and Maryland, plus the 17 others that have providing cannabis businesses relief from 280E.”



A growing number of U.S. Congressmen and women are aligned with MariMed’s take on 280E: “State-legal cannabis businesses are denied equal treatment under 280E,” said earlier this year, referencing it as “grotesquely unfair treatment” and urging his colleagues to “allow legal cannabis operations to deduct business expenses, just like any other industry.”

For more information, visit

______________

1 The natural wood, sustainable boxes tossed into the Boston Harbor were empty, floated on the surface, and pulled immediately from the harbor.

About MariMed

MariMed Inc., a multi-state cannabis operator, is dedicated to improving lives every day through its high-quality products, its actions, and its values. The Company develops, owns, and manages seed to sale state-licensed cannabis facilities, which are models of excellence in horticultural principles, cannabis cultivation, cannabis-infused products, and dispensary operations. MariMed has an experienced management team that has produced consistent growth and success for the Company and its managed business units. Proprietary formulations created by the Company’s technicians are embedded in its top-selling and award-winning products and brands, including Betty's EddiesTM, Nature’s HeritageTM, InHouseTM, Bubby’s BakedTM, K FusionTM, Kalm FusionTM, and VibationsTM: High + Energy. For additional information, visit

Media Contact:

Gretchen Giles

Grasslands: A Journalism-Minded Agency

Company Contact:

Howard Schacter

Chief Communications Officer

Email:

Phone: (781) 277-0007

Investor Relations Contact:

Steve West

Vice President, Investor Relations

Email:

Phone: (781) 277-0007



EN
13/07/2023

Underlying

To request access to management, click here to engage with our
partner Phoenix-IR's CorporateAccessNetwork.com

Reports on Worlds Online Inc

 PRESS RELEASE

MariMed’s Premium Nature’s Heritage Brand Enters Functional Mushroom M...

MariMed’s Premium Nature’s Heritage Brand Enters Functional Mushroom Market Launching Plant-Based MycroDose All-Natural Line of Wellness Products Designed to Support Overall Well-Being Now Available in Massachusetts NORWOOD, Mass., May 29, 2025 (GLOBE NEWSWIRE) -- Inc. (“MariMed”) (CSE: MRMD) (OTCQX: MRMD), the company behind the award-winning flower and concentrate brand, Nature’s Heritage™, continued to drive innovation with the launch of MycroDose by Nature’s Heritage, a vegan line of all-natural wellness products that combine the power of full-spectrum cannabis with the added benef...

 PRESS RELEASE

MariMed Reports First Quarter 2025 Earnings

MariMed Reports First Quarter 2025 Earnings NORWOOD, Mass., May 07, 2025 (GLOBE NEWSWIRE) -- MariMed Inc. (“MariMed” or the “Company”) (CSE: MRMD) (OTCQX: MRMD), a leading multi-state cannabis operator focused on improving lives every day, today announced its financial results for the first quarter ended March 31, 2025. Management Commentary “We are executing on our vision to build the best consumer packaged goods company in cannabis, and over the past quarter we continued to penetrate more storefronts and capture more market share for our innovative, high-quality portfolio of brand...

 PRESS RELEASE

MariMed Announces First Quarter 2025 Earnings Date

MariMed Announces First Quarter 2025 Earnings Date NORWOOD, Mass., April 08, 2025 (GLOBE NEWSWIRE) -- . (“MariMed” or “Company”) (CSE: MRMD) (OTCQX: MRMD), a leading cannabis consumer packaged goods company and retailer, announced today it will report first quarter 2025 financial results on May 7, 2025 after the markets close. Management will host a conference call on May 8, 2025 at 8:00 a.m. EDT to discuss financial results. A webcast will be available and can be accessed via MariMed’s Investor Relations website at . A playback of the call will also be made available on MariMed’s Invest...

 PRESS RELEASE

MariMed Promotes Ryan Crandall to Chief Commercial Officer

MariMed Promotes Ryan Crandall to Chief Commercial Officer NORWOOD, Mass., April 07, 2025 (GLOBE NEWSWIRE) -- . (“MariMed” or “Company”) (CSE: MRMD) (OTCQX: MRMD), a leading cannabis consumer packaged goods company and retailer has promoted Ryan Crandall to Chief Commercial Officer, effective immediately. In his new role, Mr. Crandall will lead the Company’s commercial strategy and activities, including Sales, Marketing, Product Development, and Retail Operations. He has served as MariMed’s Chief Revenue Officer since July 2022, and prior was the Company’s Chief Products Officer and SVP, ...

 PRESS RELEASE

MariMed’s Betty’s Eddies Expands Top-Selling Brand With Introduction o...

MariMed’s Betty’s Eddies Expands Top-Selling Brand With Introduction of THC & CBG-Infused Caramel Chews Each Betty’s Caramelt Away Chew Uses Rich, Buttery Caramel, To Create Moments of Mellow NORWOOD, Mass., April 03, 2025 (GLOBE NEWSWIRE) -- ™, the all-natural cannabis chews handcrafted to fit a variety of needs, is expanding its lineup with the introduction of delicious caramel chews: Betty’s Caramelt Away. Betty’s Eddies is one of the top-selling and award-winning brands developed and distributed by leading multi-state cannabis operator, MariMed Inc. (“MariMed”) (CSE: MRMD) (OTCQX: M...

ResearchPool Subscriptions

Get the most out of your insights

Get in touch